Article
Indian drugmaker Cipla tops Q2 profit view on solid domestic, N.America sales
Rating:
0.0
Views:
60
Likes:
1
Library:
1
Cipla , India's third-largest generic drugmaker by sales, posted a bigger-than-expected rise in second-quarter profit on Friday, boosted by strength in its key domestic and North American business.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value